Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

NCT04572451

Conditions: Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

OH2 Injection in Solid Tumors

NCT04386967

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

OH2 Injection in Melanoma

NCT05868707

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Fujian Cancer Hosptial Fuzhou, Fujian, China

Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China

View all 30 locations

View Trial Details

Recruiting

OH2 Injection in Combination With HX008 for Melanoma.

NCT04616443

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

French Clinical Datbase of Melanoma Patients (RIC-Mel)

NCT03315468

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Nantes University Hospital Nantes, France

View Trial Details

Recruiting

An International Study on Pediatric Patients With Rare Tumors.

NCT07072143

Conditions: Adenoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +65 more
Locations: Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova] Padova, Italy

View Trial Details

Recruiting

Implementation of Teledermoscopy and Artificial Intelligence

NCT05033678

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Department of dermatology, Skane University Hospital Lund, Sweden

View Trial Details

Recruiting

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

NCT07063875

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations: Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, New South Wales, Australia

Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions: Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +89 more
Locations: Loma Linda University Cancer Center Loma Linda, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

AdventHealth Celebration Celebration, Florida, United States

View all 32 locations

View Trial Details

Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions: Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations: Sharp Memorial Hospital San Diego, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Providence Saint John's Health Center Santa Monica, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

View all 27 locations

View Trial Details